Clinical Trial

Accelerated Treatment of Depressive Patients With tDCS

Study acronym: AcctDCS
Recruiting
View on ClinicalTrials.gov →
Summary
A randomized, controlled three-arm study is planned to investigate the effectiveness and feasibility of an accelerated home-based tDCS application (3 weeks of transcranial direct current stimulation at home, twice daily). A total of 30 patients with depression (10 per group), who are currently not taking and have no history of taking antidepressant medication, will be randomly assigned to either an active tDCS condition, a sham (placebo) tDCS condition, or a waitlist control group. The latter two groups will receive active tDCS treatment after completion of the control phase. This study represents a continuation of the pilot study GSUND DAHOAM (Ethics approval: 20-2091-101; Dragon et al., 2024).
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-16
notable Primary completion pushed: 2026-11-30 -> 2027-11-30 2026-06-16
minor Completion pushed: 2026-12-31 -> 2027-12-31 2026-06-16
Trial Details
NCT Number NCT07444242
Lead Sponsor University of Regensburg
Conditions Major Depressive Disorder
Enrollment 30 participants
Start Date 2026-04-01
Primary Completion 2027-11-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-15